NWBO - Northwest Biotherapeutics, Inc

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• NW Bio dips on announcing delay in submission of marketing application for DCVax
• Northwest Biotherapeutics, Advent get license for cell therapy facility in UK
• Northwest Bio in $11M loan agreement with Streeterville Capital
• Northwest achieves positive phase 3 results for glioblastoma candidate; shares rise 24%
• Northwest Bio plunges after late-stage data for lead candidate in brain cancer
• Northwest stock rises 9% as company begins cancer vaccine production at UK facility
• Northwest Biotherapeutics secures $15M financing on stock purchase rights
• Northwest Bio gaining attention as investors await phase 3 GBM data
• Northwest Biotherapeutics locks Phase 3 data from brain tumor study
• Northwest Biotherapeutics high on Flaskworks acquisition
• Northwest Biotherapeutics secures loan financing of $5M
• Northwest Biotherapeutics secures capital raise of $8M
• Northwest Biotherapeutics reports Q2 results
• Denovo Biopharma's enzastaurin Fast Track'd for brain tumor
• Northwest Biotherapeutics reports Q1 results
• Northwest Bio up on advancement of pivotal DCVax study
• Northwest Bio files for $150M mixed shelf
• Northwest Bio's DCVax-L maintains survival in late-stage brain cancer study
• Northwest Bio secures $5M in bridge funding
• Northwest Bio down 12% after underwhelming ASCO presentation